Is Your In-House Strategy Ready For The Uncertainties Of Biologic Drug Development?

By John Ward, Vice President, Engineering, Thermo Fisher Scientific

To avoid costly mistakes and wasted efforts, a company must prepare for any surprises along the drug development pathway by incorporating a flexible approach that offers multiple solutions. But is it possible to achieve efficiency and flexibility within a drug developer’s own walls, or is outsourcing pharma’s best not-so-secret weapon against today’s development uncertainties?